Search

Issue
Title
Authors
Vol 29, No 11/12 (2022)
Efficacy and safety of fixed combination insulin glargine 100 u/ml and lixisenatide in patients with type 2 diabetes mellitus depending on age and baseline HbA1C in the SOLO study
Antsiferov M.B., Demidov N.A., Safronova T.I., Mishra O.A.
PDF
(Rus)
Vol 27, No 12 (2020)
The use of fixed ratio combination of insulin glargine and lixisenatide in patients with type 2 diabetes mellitus in real clinical practice. Own clinical experience
Khamnueva L.Y., Andreeva L.S., Davydova A.V., Chugunova E.V., Tokareva N.P., Molodtsova N.Y.
PDF
(Rus)
No 16 (2012)
Rannee naznachenie insulina glargin patsientam s sakharnym diabetom 2 tipa, prediabetom i vysokim serdechno-sosudistym riskom: rezul'taty issledovaniya ORIGIN
Antsiferov M.B., Biryukova E.V., Zilov A.V.
PDF
(Rus)
Vol 27, No 4 (2020)
Clinical experience of long-term observation of the efficacy of a fixed combination of insulin glargine and GLP-1RA lixisenatide in patients with type 2 diabetes mellitus who did not reach the target glycemia values with the use of oral antidiabetic drugs
Mkrtumyan A.M., Markova T.N.
PDF
(Rus)
No 3 (2012)
TIMELY ADMINISTRATION OF INSULIN THERAPY IN TYPE 2 DIABETES MELLITUS
Chernikova N.A., Prudnikova M.A., Chernikova N.A., Prudnikova M.A.
No 4 (2018)
MOSCOW EXPERIENCE OF APPLICATION OF A NEW LONG-ACTING INSULIN ANALOGUE
Demidov N.A., Antsiferov M.B.
PDF
(Rus)
No 3 (2011)
RESULTS OF OBSERVATIONAL PROGRAM ON USE OF INSULIN GLARGINE (LANTUS®) IN COMBINATION WITH ORAL HYPOGLYCEMIC AGENTS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN ROUTINE CLINICAL PRACTICE
Glinkina I.V., Romantsova T.I., Glinkina I.V., Romantsova T.I.
No 16 (2017)
The use of insulin glargine 300 lU/ml (Toujeo SoloStar®) in real clinical practice
Antsiferov M.B.
PDF
(Rus)
No 3 (2010)
Use of long-acting insulin analogues in type 2 diabetes mellitus treatment (according to the data of international and Russian registries)
Antsiferov M.B., Antsiferov M.
No 16 (2016)
Clinical characteristics and practical aspects of the use of new basal insulin glargine 300 U/ml Toujeo SoloStar®
Antsiferov M.B.
PDF
(Rus)
No 3 (2009)
Possibilities of insulin glargine (Lantus ®) use for treatment of type 2 diabetes mellitus in the outpatient endocrinology services: an analysis of the register LAUREL
Antsiferov M.B., Petraneva E.V., Anciferov M.B., Petraneva E.V.
No 5 (2015)
Personalizirovannyy podkhod k rezhimu insulinoterapii - est' li mesto strakhu gipoglikemiy?
Volkova N.I., Porksheyan M.I.
PDF
(Rus)
No 16 (2014)
Issledovanie ORIGIN (Outcome Reduction with Initial Glargine INtervention) 2 goda spustya: chto novogo?
Glinkina I.V.
PDF
(Rus)
No 16 (2013)
Bazal'naya insulinoterapiya: opyt klinicheskoy praktiki
Chernikova N.A., Ametov A.S., Antsiferov M.B.
PDF
(Rus)
1 - 14 of 14 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies